V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219758 | 20088781 | null | 67.6 | Palliative (P) | null | 2018-09-26 | ESPAC-4 TRIAL | 02 | N | ANAGRELIDE | 100625503 |
| 20219760 | 20088782 | 0 | 0 | Palliative (P) | 2018-12-28 | 2018-12-28 | Hydroxycarbamide | 02 | N | CAPECITABINE + STREPTOZOCIN | 100369989 |
| 20219987 | 20088784 | 1.31 | 55.2 | Palliative (P) | 2017-08-03 | 2017-08-17 | ACELARATE Trial | N | N | CAPECITABINE + STREPTOZOCIN | 100518188 |
| 20220087 | 20088786 | 1.68 | 55.3 | null | 2015-10-29 | 2015-11-23 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100619517 |
| 20220157 | 20088787 | 1.79 | 89.6 | Palliative (P) | 2018-01-20 | 2018-02-02 | ECarboX | N | N | CYCLOPHOSPHAMIDE | 100689264 |
| 20220177 | 20088788 | 1.56 | 71 | Neo-adjuvant (N) | 2021-07-25 | 2021-07-25 | null | 02 | N | MCX | 100116607 |
| 20220308 | 20088789 | 1.64 | 81.1 | Palliative (P) | 2021-08-27 | 2021-08-28 | Raltitrexed | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100517890 |
| 20220442 | 20088791 | 1.56 | 74.5 | null | 2018-07-17 | 2018-07-17 | ACTICCA-1 Trial | null | N | PLATO TRIAL | 100097077 |
| 20220476 | 20088792 | 1.75 | 60 | Palliative (P) | 2019-11-18 | 2019-11-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | INTERFERON ALFA | 100986042 |
| 20220479 | 20088793 | 1.81 | 65 | Palliative (P) | 2017-08-13 | 2017-08-13 | Y-90 | 01 | N | RITUXIMAB | 100467656 |
| 20220483 | 20088794 | 1.78 | 85 | Palliative (P) | 2019-04-10 | 2019-04-12 | Sunitinib | N | N | DOCETAXEL | 100673051 |
| 20220493 | 20088795 | 1.74 | 79.8 | null | 2019-06-21 | 2019-07-12 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 101463349 |
| 20220576 | 20088796 | 1.67 | 67.9 | Palliative (P) | 2017-05-19 | 2017-05-23 | Irinotecan 14day | Y | N | GEMCITABINE + PACLITAXEL | 100401732 |
| 20220796 | 20088798 | 1.68 | null | Palliative (P) | 2016-06-17 | 2016-07-19 | Bortezomib + MELPHALAN | 01 | N | HEPATOBLASTOMA RELAPSE VI | 100424166 |
| 20220850 | 20088799 | 1.58 | 62 | Palliative (P) | 2019-06-10 | 2019-06-10 | PLATO Trials | 02 | null | PLATO TRIAL | 101458418 |
| 20220975 | 20088800 | 1.61 | 49 | Palliative (P) | null | 2017-03-10 | PEMBROLIZUMAB | null | N | NOT MATCHED | 100880778 |
| 20221152 | 20088801 | 1.78 | 72.4 | null | 2018-02-16 | 2018-02-22 | Fluorouracil + Folinic + RT Bossett | 02 | Y | CAPITAL TRIAL | 101478129 |
| 20221153 | 20088802 | 1.63 | 56 | 03 | 2019-09-23 | 2019-09-23 | ECarboX | N | N | ESPAC TRIAL | 101493919 |
| 20221572 | 20088804 | 1.61 | 71 | null | null | 2016-12-25 | SCOPE 2 TRIAL | 01 | N | OXALIPLATIN | 100126530 |
| 20221657 | 20088805 | 1.7 | 68.5 | 03 | 2019-08-30 | 2019-09-06 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | NEO-AEGIS TRIAL | 101042109 |
| 20221836 | 20088807 | null | 93 | null | 2016-09-09 | 2016-09-17 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101338877 |
| 20221863 | 20088808 | 1.66 | 63 | Palliative (P) | 2019-01-07 | 2019-01-08 | Rituximab | 02 | Y | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101074111 |
| 20222527 | 20088809 | 1.73 | 82 | 03 | 2019-08-25 | 2019-09-10 | Capecitabine + Streptozocin | 02 | N | FOXTROT TRIAL | 100265649 |
| 20222590 | 20088810 | 1.55 | null | 03 | 2018-05-21 | 2018-05-24 | CARBOPLATIN + FLUOROURACIL | 02 | N | CAP + RT | 100330547 |
| 20222971 | 20088811 | 1.78 | 76 | null | 2019-05-04 | 2019-05-19 | Irinotecan | N | N | BENDAMUSTINE + RITUXIMAB | 100420758 |
| 20223133 | 20088812 | 1.66 | 63.3 | Adjuvant (A) | 2019-06-19 | 2019-06-25 | PLATO Trials | 02 | Y | PLATO TRIAL | 100084661 |
| 20223202 | 20088813 | 1.57 | 66.2 | null | 2019-01-14 | 2019-01-19 | CHOP R - 21 days | 02 | N | IPILIMUMAB + NIVOLUMAB | 101388397 |
| 20223330 | 20088814 | 1.7 | 64.5 | null | 2016-07-26 | 2016-08-05 | CARBOPLATIN + FLUOROURACIL | 02 | N | ACTICCA-1 TRIAL | 100415963 |
| 20224209 | 20088815 | 1.61 | 64 | Palliative (P) | 2019-04-06 | 2019-04-06 | Fluorouracil + Folinic + RT Bossett | null | N | ANAGRELIDE | 100945641 |
| 20224260 | 20088816 | 1.52 | 65 | Palliative (P) | 2020-04-10 | 2020-04-23 | PEMBROLIZUMAB | 02 | N | ACTICCA-1 TRIAL | 101152026 |
| 20224380 | 20088817 | 1.41 | 52.7 | Palliative (P) | 2017-03-22 | 2017-03-27 | CARBOPLATIN + FLUOROURACIL | 02 | null | EC | 100406326 |
| 20224389 | 20088818 | 1.78 | 82.6 | 03 | 2019-04-23 | 2019-04-23 | EEF or EOF | 02 | N | BACILLUS CALMETTE-GUERIN | 101123032 |
| 20224442 | 20088819 | 1.8 | 81 | 03 | 2018-08-06 | 2018-08-07 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101312033 |
| 20224447 | 20088820 | 1.81 | 60.2 | Palliative (P) | 2018-09-24 | 2018-09-24 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101077473 |
| 20224729 | 20088821 | 1.67 | null | null | 2019-03-16 | 2019-04-06 | Cetuximab + Radiotherapy Maint | 02 | N | PEMBROLIZUMAB | 101570767 |
| 20224829 | 20088822 | null | 74.9 | Palliative (P) | null | 2018-12-09 | CAP + RT | 01 | N | NEO-AEGIS TRIAL | 100465200 |
| 20225073 | 20088823 | 1.68 | 93.5 | 03 | null | 2018-10-20 | EEF or EOF | 02 | N | ARISTOTLE TRIAL | 100693247 |
| 20225316 | 20088824 | 0 | 0 | Palliative (P) | 2018-08-23 | 2018-09-03 | EVEROLIMUS | N | N | DACARBAZINE + DOXORUBICIN | 101453265 |
| 20225397 | 20088825 | 0 | 13.5 | Palliative (P) | 2018-04-21 | 2018-04-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | IPILIMUMAB + NIVOLUMAB | 100344417 |
| 20225534 | 20088826 | null | 60.8 | 03 | 2018-10-31 | 2018-12-01 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | DOXORUBICIN | 101407200 |
| 20001315 | 20088828 | 1.57 | 71.9 | Palliative (P) | 2018-05-19 | 2018-05-19 | Bortezomib +/- Dexamethasone | 01 | N | ECARBOX | 101739285 |
| 20003808 | 20088829 | 1.49 | 108 | Palliative (P) | 2018-06-05 | 2018-06-25 | Carboplatin + Pemetrexed | 02 | N | DOCETAXEL | 100348897 |
| 20012445 | 20088832 | 1.67 | 76.1 | 03 | 2020-05-14 | 2020-05-17 | PACLITAXEL | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100328123 |
| 20013659 | 20088833 | null | 60 | 03 | 2019-04-01 | 2019-04-15 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | CAPECITABINE + STREPTOZOCIN | 100521861 |
| 20013726 | 20088834 | 1.62 | 0 | 03 | 2017-04-27 | 2017-05-03 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | BORTEZOMIB | 100700197 |
| 20015137 | 20088835 | 1.57 | 79 | Curative (C) | null | 2020-03-23 | Carboplatin + Pemetrexed | null | N | IBRUTINIB | 100216967 |
| 20015188 | 20088836 | 1.75 | null | Neo-adjuvant (N) | 2019-10-04 | 2019-10-15 | Docetaxel | 01 | N | SCOPE2 TRIAL | 101757171 |
| 20018874 | 20088839 | 1.64 | 52.7 | Palliative (P) | 2020-09-23 | 2020-09-23 | Cisplatin + Fluorouracil + RT 5day | N | N | LENALIDOMIDE | 100439415 |
| 20018993 | 20088840 | 1.71 | 90 | Palliative (P) | 2019-12-08 | 2019-12-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101406014 |
| 20021080 | 20088842 | 1.7 | 112 | Palliative (P) | 2018-07-12 | 2018-07-20 | EOF | 02 | N | RALTITREXED | 100564750 |